NH Korindo Sekuritas Indonesia
Menu
  • OUR SERVICE
    • News & Research
      • News
      • Equity Report
      • Research Fixed Income
      • Company Report
      • Outlook
      • Special Notation
    • Equity
    • Fixed Income
    • Margin
    • Bonds
    • Investment Banking
      • IPO
      • E-IPO
    • Wealth Management
      • Mutual Funds
    • Download Center
      • Download NAIK
      • Documents
    • Academy
      • Stock Dictionary
      • Stock Education
  • ABOUT US
    • Our Firm
    • Our People
    • Our Branch
    • Corporate Governance
    • Careers
    • FAQ
  • CONTACT
  • Register
  • EN
    • ID
  • ID
  • EN

SIDO – Satisfactory 4Q20 Result

  • Author
  • Recent Posts
Putu Chantika
Putu Chantika
Analyst - Consumer, Retail
Putu Chantika
Latest posts by Putu Chantika (see all)
  • ICBP – Supported by Topline Growth - December 20, 2021
  • ACES – Slowdown in 3Q21 Sales - December 7, 2021
  • ERAA – Continue on Growth Path - December 1, 2021

SIDO is our top pick in the healthcare sector given its resilience performance amid the unfavorable economic condition, with the healthiest balance sheet among peers, and benefited from rising health awareness. We believe key initiatives from management will accelerate the performance this year.

Download full report HERE.

Share This Article

Related Article


XA Initiation Report | PT Soechi Lines Tbk. (SOCI) — Fueling Up, Bulking Up

12 Feb 2026

XA Initiation Report | PT Soechi Lines Tbk. (SOCI) — Fueling Up, Bulking Up   By Ezaridho ...

TRIN : Strategic Pivot Unlocks Future Value

10 Feb 2026

PT Perintis Triniti Properti Tbk. (TRIN) is a property developer established in 2009 and listed on the Indonesia Stock Exchange in 2020. The company focuses on mixed-use, residential, and commercial developments, with key projects including Collins Boulevard, Marc’s Boulevard, Sequoia Hills, Holdwell Business Park, and the TanaMori development in Labuan Bajo.

Company Report | [SIDO IJ] Continuing To Widen Bottom-Line Margin, Higher Overseas Revenue, And Expand Into Younger Consumer Bases

26 Mar 2025

FY24 Total Revenue achieved of 10% to IDR 3,919 bn. There was robust top-line growth across all revenue segments Herbal and Supplements with 6% YoY; Food and Beverages (18% YoY); and Pharmaceutical (10% YoY).

 

More Article

Analysis Report

12 Feb 2026

XA Initiation Report | PT Soechi Lines Tbk. (SO...

XA Initiation Report | PT Soechi Lines Tbk. (SOCI) — Fueling Up, Bulking Up   By E...

READ MORE

Daily Report

12 Feb 2026

Daily Report | 12 Feb 2026

Today’s Outlook :   • US MARKET :     • EUROPEAN MARKET :   •  ASIA...

READ MORE

Daily Report

11 Feb 2026

Daily Report | 11 Feb 2026

Today’s Outlook :   • US MARKET :       • EUROPEAN MARKET :   ...

READ MORE

Contact Us

  • Treasury Tower 51th Floor, District 8, SCBD Lot 28, Jl. Jend. Sudirman No.Kav 52-53, RT.5/RW.3, Senayan, Kebayoran Baru, South Jakarta City, Jakarta 12190
  • cso@nhsec.co.id
  • +62 21 5088 9100 (Representative Number)
    +62 21 5088 9102 (CS Number)
  • +628 118 198 111 (Official Whatsapp 1)
    +6281 67 0000 5 (Official Whatsapp 2)

Link

  • Our Firm
  • Research
  • Our People
  • Download
  • Dictionary
  • FAQ

Certified By

Data yang ditampilkan di aplikasi PT NH Korindo Sekuritas Indonesia berasal dari BEI dan telah disetujui untuk ditampilkan.

PT NH Korindo Sekuritas Indonesia berizin dan diawasi oleh Otoritas Jasa Keuangan (OJK).


© Copyright 2026 NH Korindo Sekuritas. All rights reserved.